217 related articles for article (PubMed ID: 31850222)
1. Prognostic and Clinicopathological Significance of Long Non-coding RNA PANDAR Expression in Cancer Patients: A Meta-Analysis.
Han L; Wang B; Wang R; Wang Z; Gong S; Chen G; Telemacque D; Feng Y; Xu W
Front Oncol; 2019; 9():1337. PubMed ID: 31850222
[No Abstract] [Full Text] [Related]
2. LncRNA PANDAR as a prognostic marker in Chinese cancer.
Ma PJ; Guan QK; Xu DW; Zhao J; Qin N; Jin BZ
Clin Chim Acta; 2017 Dec; 475():172-177. PubMed ID: 29066211
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic value of lncRNA PANDAR expression in solid tumors: Evidence from a systematic review and meta-analysis.
Mehrad-Majd H; Akhtari J; Haerian MS; Ravanshad Y
J Cell Physiol; 2019 Apr; 234(4):4206-4216. PubMed ID: 30191982
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA PANDAR overexpression serves as a poor prognostic biomarker in oral squamous cell carcinoma.
Huang Z; Sang T; Zheng Y; Wu J
Int J Clin Exp Pathol; 2018; 11(5):2728-2734. PubMed ID: 31938389
[TBL] [Abstract][Full Text] [Related]
6. LncRNA PANDAR is a Novel Prognostic Biomarker in Patients with Cancer: a Meta-Analysis.
Tian L; Chen X; Lun L; Tian Q; Wang Q; Li H; Song J; Jing X; Zhang Y; Tian R
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775883
[TBL] [Abstract][Full Text] [Related]
7. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma.
Xu Y; Tong Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Xie L
BMC Cancer; 2017 May; 17(1):373. PubMed ID: 28545465
[TBL] [Abstract][Full Text] [Related]
8. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
Zhang S; Qiu D; Xie X; Shen Y
BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and clinicopathological significance of long noncoding RNA HOXA11-AS expression in human solid tumors: a meta-analysis.
Mu S; Ai L; Fan F; Sun C; Hu Y
Cancer Cell Int; 2018; 18():1. PubMed ID: 29308050
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of LncRNA PANDAR predicts a poor prognosis in gastric cancer.
Ma P; Xu T; Huang M; Shu Y
Biomed Pharmacother; 2016 Mar; 78():172-176. PubMed ID: 26898439
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of long non-coding RNA breast cancer anti-estrogen resistance 4 in human cancers: A meta-analysis.
Meng Y; Liu YL; Li K; Fu T
Medicine (Baltimore); 2019 May; 98(21):e15793. PubMed ID: 31124974
[TBL] [Abstract][Full Text] [Related]
14. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of LncRNA PANDAR predicts poor prognosis and promotes cell proliferation in cervical cancer.
Huang HW; Xie H; Ma X; Zhao F; Gao Y
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4529-4535. PubMed ID: 29131264
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of long non-coding RNA PVT1 as a novel biomarker in various cancers: a meta-analysis.
Zhu S; Shuai P; Yang C; Zhang Y; Zhong S; Liu X; Chen K; Ran Q; Yang H; Zhou Y
Oncotarget; 2017 Dec; 8(68):113174-113184. PubMed ID: 29348896
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.
Zhan Y; Lin J; Liu Y; Chen M; Chen X; Zhuang C; Liu L; Xu W; Chen Z; He A; Zhang Q; Sun X; Zhao G; Huang W
J Exp Clin Cancer Res; 2016 May; 35(1):83. PubMed ID: 27206339
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
[TBL] [Abstract][Full Text] [Related]
20. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients.
Li X; Wang F; Sun Y; Fan Q; Cui G
Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
